Wednesday, November 25, 2009, 12:40am EST - Canadian Markets open in 8 hours and 50 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Medicines Co. (MDCO)

 On Nov 24: 7.70 USD  Down 0.04 (0.52%)  
MORE ON MDCO
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
The Medicines Company (NasdaqNM:MDCO) Delayed quote dataEdit
After Hours: 7.74 Up 0.04 (0.52%) as of 5:00pm EST on 11/24/09
Last Trade: 7.70 USD
Trade Time: Nov 24
Change: Down 0.04 (0.52%)
Prev Close: 7.74
Open: 7.74
Bid: 7.00 x 200
Ask: 8.60 x 100
1y Target Est: 10.00
Day's Range: 7.51 - 7.78
52wk Range: 6.15 - 16.77
Volume: 135,715
Avg Vol (3m): 613,632
Market Cap: 407.11M
P/E (ttm): N/A
EPS (ttm): -0.13
Div & Yield: N/A (N/A%)
Medicines Co. (MDCO)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add MDCO to Portfolio   Download Data

HEADLINES
• Zacks Bull and Bear of the Day Highlights: CPFL Energia, The Medicines Company, Eastman Chemical Co., Dow Chemical Company and Dupont
Zacks.com (Thu, Nov 19)
• Medicines Co. (MDCO)
Zacks.com (Thu, Nov 19)
• The Medicines Company AHA Data Review Call scheduled for 8:30 am ET today
CCBN (Mon, Nov 16)
• Medicines Co. blood thinner still has hope: doctors
at Reuters (Sun, Nov 15)
• The Medicines Company's Full Analysis of CHAMPION Phase III Data Shows Cangrelor Significantly Improves Patient Outcomes Following PCI
Marketwire (Sun, Nov 15)
• MEDICINES CO /DE Financials
EDGAR Online Financials (Fri, Nov 13)
• Cleviprex Results Reported From Study in Patients With Intracerebral Hemorrhage
Marketwire (Thu, Nov 12)
• MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
• Medicines Co. Misses & Cuts
Zacks.com (Mon, Nov 2)
• MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Wed, Oct 28)
• The Medicines Company Earnings Call scheduled for 8:30 am ET today
CCBN (Wed, Oct 28)
• The Medicines Company Reports Third Quarter 2009 Financial Results
Marketwire (Wed, Oct 28)
• Q3 2009 The Medicines Company Earnings Release - Before Market Open
CCBN (Wed, Oct 28)
More Headlines for MDCO...
ANALYST
EPS Est (next year) (Dec-09) : -0.22
EPS Est (in 2 years) (Dec-10) : 0.25
Avg Rec (current)*: 2.7
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
The Medicines Company, a pharmaceutical company, provides medicines for the treatment of critical care patients worldwide. It markets Angiomax, an intravenous direct thrombin inhibitor for use as an anticoagulant in combination with aspirin in pat...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices